540 related articles for article (PubMed ID: 19656174)
1. Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.
Massart R; Guilloux JP; Mignon V; Sokoloff P; Diaz J
Eur J Neurosci; 2009 Aug; 30(3):397-414. PubMed ID: 19656174
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
3. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
4. Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats.
Ferrario JE; Rojas-Mayorquín AE; Saldaña-Ortega M; Salum C; Gomes MZ; Hunot S; Raisman-Vozari R
J Neurochem; 2008 Oct; 107(2):443-52. PubMed ID: 18752647
[TBL] [Abstract][Full Text] [Related]
5. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
Carta AR; Tronci E; Pinna A; Morelli M
Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929
[TBL] [Abstract][Full Text] [Related]
6. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
7. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
[TBL] [Abstract][Full Text] [Related]
8. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P
Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199
[TBL] [Abstract][Full Text] [Related]
10. Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
Lee J; Gomez-Ramirez J; Johnston TH; Visanji N; Brotchie JM
Synapse; 2008 Apr; 62(4):310-3. PubMed ID: 18241048
[TBL] [Abstract][Full Text] [Related]
11. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.
Santini E; Alcacer C; Cacciatore S; Heiman M; Hervé D; Greengard P; Girault JA; Valjent E; Fisone G
J Neurochem; 2009 Feb; 108(3):621-33. PubMed ID: 19187092
[TBL] [Abstract][Full Text] [Related]
12. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
Mura A; Feldon J; Mintz M
Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
[TBL] [Abstract][Full Text] [Related]
13. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M
Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684
[TBL] [Abstract][Full Text] [Related]
14. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
16. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
[TBL] [Abstract][Full Text] [Related]
17. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats.
Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T
Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111
[TBL] [Abstract][Full Text] [Related]
18. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
Fiorentini C; Rizzetti MC; Busi C; Bontempi S; Collo G; Spano P; Missale C
Mol Pharmacol; 2006 Mar; 69(3):805-12. PubMed ID: 16365282
[TBL] [Abstract][Full Text] [Related]
19. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
Glavan G
Brain Res; 2008 Oct; 1236():216-24. PubMed ID: 18721798
[TBL] [Abstract][Full Text] [Related]
20. De novo and long-term l-Dopa induce both common and distinct striatal gene profiles in the hemiparkinsonian rat.
El Atifi-Borel M; Buggia-Prevot V; Platet N; Benabid AL; Berger F; Sgambato-Faure V
Neurobiol Dis; 2009 May; 34(2):340-50. PubMed ID: 19233275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
